Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

123

306 CPAP Therapy Tempers Monocytosis and Hematopoietic Activation Among Newly-diagnosed OSA/ O. Cohen, New York, NY 307 Senolytic Adjuvant Treatment Ameliorates Sleep Propensity and Explicit Memory in a Murine Model of OSA Receiving “Adherent” CPAP Therapy/ C. Puech, Columbia, MO 308 Association of TNF- a (-308 G/A) Gene Polymorphism With the Changes in Circulating TNF- a Levels Over 12 Months in Response to CPAP Treatment in the RICCADSA Cohort/ Y. Peker, Istanbul, Turkey 309 Assessing Vascular Inflammation and Atherosclerosis Heterogeneity in Sleep Apnea Using Machine Learning Approaches and Multimodal Imaging Before and After CPAP/ V. Kundel, New York, NY 310 Effects of HIF-1 a Inhibition on the Metabolic Effects of Intermittent Hypoxia in a Rodent Model of Diabetes Mellitus/ U.J. Magalang, Columbus, OH 311 Obstructive Sleep Apnea (OSA)-related Intermittent Hypoxia (IH) Induces Hepatic Senescence in a Mouse Model/ Y. Wang, Changsha, China 312 Intermittent Hypoxia Is Associated With Increased Mortality in a Mouse Model of COVID-19/ L. Barnes, La Jolla, CA 313 Impaired Endothelial Cell Cholesterol Trafficking in Obstructive Sleep Apnea/ A. Chang, New York, NY 314 Effect of Intermittent Hypoxia on Genes Associated With Cardiac Muscle Contraction/ R. Cetin-Atalay, Chicago, IL 315 Pre-treatment With VEGF Alleviates Some of the Metabolic Impairments in a Murine Model of Sleep Apnea/ O. Yajuk, Jerusalem, Israel

502 Lung Cancer Risk Assessment Among People Exposed to Secondhand Tobacco/ R. Yip, New York, NY 503 The Prediction Model “Stress Test:” Comparison of Lung Cancer Prediction Models’ Performance on a Challenging Peripheral Pulmonary Lesion Registry/ B.E. Heideman, Nashville, TN 504 Lung Cancer in Asian Indian Females: Identification of Disease-specific Characteristics and Outcome Measures Over a 12-year Period/ A. Mohan, New Delhi, India 505 Pneumonitis in Stage III Non-small Cell Lung Cancer: Who Is at Risk?/ D. Dustin, Providence, RI 506 Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors for Treatment of Malignant Pleural Effusion in EGFR-Mutant Lung Adenocarcinoma Patients/ K.L. Lee, Taipei, Taiwan 507 The Effectiveness of Local Consolidative Therapy for Advanced Lung Adenocarcinoma Harboring EGFR Mutation Treated With First-line Afatinib/ Y.-C. Tsai, Kaohsiung, Taiwan 508 Association Between the Distressed Community Index and Outcomes Among Patients With Lung Cancer/ S.O. Okoli, New Orleans, LA 509 The Trajectory of Lung Cancer Diagnosis and Management During the COVID Pandemic in the Veteran Population/ S.O. Okoli, New Orleans, LA 510 Timeliness of Care Among Patients With Small Cell Lung Cancer Evaluated by a Multi-disciplinary Team/ M. Block, Grand Rapids, MI 511 Multiple Annual Low Dose CT Scans Needed to Detect Malignancy: Number Needed to Scan ³ 4/ E.L. Bernstein, New Haven, CT 512 Disparities in Lung Cancer Screening in a Sample of Veterans/ E.L. Bernstein, New Haven, CT 513 Time to Diagnosis and Treatment of Non-small Cell Lung Cancer in Patients Undergoing Lung Cancer Screening/ E.L. Bernstein, New Haven, CT 514 The Presence of Targetable Mutations in Metastatic Non-Small Cell Lung Cancer Patients With Malignant Pleural Disease Is Not Associated With Improved Survival/ C. Gilbert, Charleston, SC 515 USPSTF-eligible Asian-Americans Receiving Lung Cancer Screening Have Lower Rates of Tobacco Cessation, Annual Adherence, and Screen-detected Lung Cancer/ B. Tasevac, Philadelphia, PA 516 Screening Beyond the Nodule: Annual LDCT as a Screening Tool for Other Comorbid Conditions/ A. Herring, Baltimore, MD

BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

A110 LUNG CANCER RISK, SCREENING, TREATMENT, AND OUTCOMES 2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Room 151 B (Street Level)

Poster Viewing

2:15-3:00 3:00-4:15

Discussion

Chairing: L.T. Tanoue, MD, New Haven, CT

J. Thompson, MD, MS, Philadelphia, PA 501 Effect of Removing Race and Ethnicity From Lung

Cancer Prediction Models on Disparities in Eligibility for Lung Cancer Screening/ H. Katki, Rockville, MD

ATS 2023 • Washington, DC